U.S. Household Products Stock News

If you are wondering whether Colgate-Palmolive at around US$96.67 is still a sensible entry or hold, the key question is how that price stacks up against the company’s underlying value. The stock has recently delivered returns of 1.1% over 7 days, 13.5% over 30 days, 24.4% year to date, 9.9% over 1 year, 43.1% over 3 years and 45.8% over 5 years, which naturally raises questions about how much of the story is already reflected in the share price. Recent news flow around Colgate-Palmolive has...

If you are wondering whether Core Natural Resources is still offering good value after its run in recent years, this article will walk through what the current share price might be implying. The stock recently closed at US$86.84, with a 2.4% decline over 7 days, a 9.2% decline over 30 days and a 3.4% decline year to date, while the 1 year return stands at 16.0%, the 3 year return at 53.7% and the 5 year return is roughly 7x. Recent coverage has focused on Core Natural Resources' position in...

Why Medical Properties Trust is back on investors’ radar Medical Properties Trust (MPT) has drawn fresh attention after returning to quarterly profitability, lifting its dividend and working through tenant bankruptcies and high leverage via property sales and new leases. See our latest analysis for Medical Properties Trust. The recent fourth quarter earnings return to profit, dividend increase and progress on tenant issues have coincided with a 13.83% 1 month share price return and a 13.39%...

Medtronic (MDT) is reshaping its business with plans to spin off its Diabetes segment through a MiniMed Group IPO, while advancing its Stealth AXiS spine surgery platform, moves that directly affect how investors may view the stock. See our latest analysis for Medtronic. Despite a recent soft patch, with a 30 day share price return of 3.99% decline and a 90 day share price return of 7.97% decline, Medtronic’s 1 year total shareholder return of 10.07% and 3 year total shareholder return of...

Early Comstock Resources investor Dallas C. Salazar has launched a new family office, Two Texas Presidents, focused on energy sector investments. Salazar has been involved in prior acquisition events at Comstock Resources, which brought him significant gains. The new family office keeps attention on Comstock Resources' history with high profile energy investors such as Salazar. For investors watching Comstock Resources (NYSE:CRK), the launch of Two Texas Presidents adds context around the...

Strategy Inc., formerly MicroStrategy, recently completed its 100th Bitcoin purchase, adding 592 BTC for about US$39.8 million and funding the acquisition by selling roughly 297,940 common shares, reinforcing Bitcoin as its primary treasury reserve asset. This milestone underlines Strategy’s singular commitment to an aggressive Bitcoin accumulation model at a time when most corporate treasuries have stepped back, intensifying debate over balance-sheet risk and shareholder dilution. Next, we...

Argan (AGX) has drawn fresh attention after announcing two large Texas contracts to build power plants that will supply electricity to data centers running AI workloads, directly connecting its project pipeline to AI driven power demand. See our latest analysis for Argan. The latest Texas wins sit against a sharp share price run, with Argan’s 30 day share price return of 25.13% and year to date share price return of 35.70% combining with a very large 1 year total shareholder return that...

Truist Financial (NYSE:TFC) is offering clients access to SEC registered spot Bitcoin ETFs through Truist Investment Services Inc. The bank has also launched open banking connectivity in partnership with Mastercard, giving clients new ways to link and manage financial data. These moves expand Truist Wealth's product shelf and introduce new digital tools for clients who want broader choice and more control. For a large US regional bank focused on retail, wealth, and commercial banking, this...

Earlier this week, F&G Annuities & Life, Inc. and Voya Financial, Inc. announced that F&G's annuity solutions will be distributed through Voya's Wealth Management platform, giving Voya financial professionals access to a broader suite of retirement and income protection products supported by education and product expertise. This collaboration highlights how Voya is using third-party partnerships to deepen its retirement offering without building every annuity product in-house, potentially...

MakeMyTrip (MMYT) has drawn fresh attention after reporting strong third quarter leisure demand, higher accommodation volumes and a larger buyback authorization, alongside a new AI-led travel planning collaboration with OpenAI. See our latest analysis for MakeMyTrip. At a share price of $56.97, MakeMyTrip has faced a 10.64% 1 month share price return decline and a 30.43% year to date slide. However, its 3 year total shareholder return of 116.70% points to much stronger longer term momentum...

e.l.f. Beauty (NYSE:ELF) has expanded its collaboration with Liquid Death, introducing a beverage inspired lip balm that uses parody driven branding. The company has also added former Church & Dwight chief executive Matthew Farrell to its board, bringing large scale consumer brand leadership experience. e.l.f. Beauty operates in the color cosmetics and broader beauty market, where social media, creator partnerships and limited edition drops are important drivers of consumer attention. The...

Centrus Energy (LEU) is back in focus after a series of announcements regarding its role as the only U.S. Nuclear Regulatory Commission licensed producer of high assay low enriched uranium, as well as a multibillion dollar capacity expansion. See our latest analysis for Centrus Energy. Those announcements and contracts have landed during a volatile stretch, with the share price at US$210.63 after a 1-day share price return of 1.67% and a 30-day share price return decline of 25.23%. The 1-year...

United Therapeutics has introduced a new soft mist inhaler that is positioned as a direct competitor to MannKind's Tyvaso DPI. The new device is described as offering reduced side effects, including less coughing, compared with dry powder inhalers. This development raises questions about the durability of MannKind's royalty stream from Tyvaso DPI and could influence investor expectations for NasdaqGM:MNKD. MannKind, trading on NasdaqGM:MNKD, is closely tied to royalties from Tyvaso DPI, so...

If you are wondering whether MongoDB's current share price still makes sense, you are not alone. This article will focus on what that price could mean for value focused investors. The stock last closed at US$314.99, with returns of a 13.2% decline over 7 days, a 23.4% decline over 30 days, a 21.2% decline year to date, a 17.4% gain over 1 year, 50.0% over 3 years, and a 10.5% decline over 5 years, which hints at changing expectations and risk perceptions over different timeframes. Recent...

NetApp (NTAP) heads into its upcoming earnings release with investor attention focused on two fronts: recent sector driven valuation resets and the company’s push into AI infrastructure, Keystone storage services, and public cloud offerings. See our latest analysis for NetApp. The recent 1 day share price return of 2.01% to US$101.88 comes after weeks of mixed signals, with a 30 day share price return of 3.11% but a 90 day decline of 6.75%. The 1 year total shareholder return of 16.47%...

In February 2026, Critical Metals Corp. filed a US$25.17 million shelf registration for 2,777,600 ordinary shares, while also reporting its strongest rare earth element assay results to date from the Hill Deposit at the Tanbreez Heavy REE Project. The combination of insider plans to sell a large block of shares and encouraging heavy rare earth grades creates an unusual mix of financing and project-quality signals for investors to weigh. We’ll now examine how the strong Tanbreez assay...

Why Arista Networks Stock Is Back in Focus Arista Networks (ANET) is back on many investors’ screens after tech stocks rebounded on easing tariff worries, fresh AI infrastructure news, and management’s recently raised guidance tied to AI driven revenue expectations. See our latest analysis for Arista Networks. At a share price of US$132.89, Arista has seen a 3.2% one day share price return but a 7.5% 30 day share price decline. Its 1 year total shareholder return of 37.9% and very large 5...

Why Ducommun’s upcoming Q4 report matters today Ducommun (DCO) is in focus today as it reports Q4 2025 results before the market opens, with investors watching how expected 10.3% year on year revenue growth compares with last quarter’s 5.5% increase. See our latest analysis for Ducommun. The share price has gained 13.9% over the past month and 38.3% over the last 90 days, while the 1 year total shareholder return of 120.8% points to strong momentum ahead of today’s $126.77 print and the...

Why recent commentary on PennyMac Financial Services (PFSI) is drawing investor attention Recent commentary flagging a 10.4% annual sales decline and falling earnings per share over the past five years at PennyMac Financial Services (PFSI) has put the mortgage specialist’s fundamentals back in the spotlight. See our latest analysis for PennyMac Financial Services. At a share price of US$92.74, PennyMac Financial Services has seen a 1 day share price return of 1.69%. However, the 30 day share...

Dana (DAN) is preparing for a leadership handover after naming Byron Foster as its next CEO and President, with current CEO R. Bruce McDonald set to remain Chairman to support a structured transition. See our latest analysis for Dana. The leadership news comes on top of a period of strong momentum, with a 30-day share price return of 17.16% and a 90-day share price return of 59.16%, while the 1-year total shareholder return of 135.16% points to a very strong multiyear outcome. If this...

Soleno Therapeutics (SLNO) is in focus after reporting Q4 and full year 2025 results that moved from prior net losses to net income, with earnings per share also turning positive and topping analyst expectations. See our latest analysis for Soleno Therapeutics. The earnings surprise and shift to profitability come after a mixed period for the stock, with a 1 day share price return of 4.72% and 7 day share price return of 6.22% contrasting with a 90 day share price return decline of 17.24%,...

In February 2026, PG&E Corporation declared a regular first-quarter cash dividend of US$0.05 per share and completed a US$1.00 billion fixed-to-floating junior subordinated notes offering, following its full-year 2025 results showing revenue of US$24,935 million and net income of US$2,593 million. PG&E’s collaboration with Sunrun on a distributed power plant program highlights how customer-supplied solar and storage can support grid reliability while potentially deferring traditional...

CoStar Group FY 2025 results: revenue climbs while profitability tightens CoStar Group (CSGP) has wrapped up FY 2025 with Q4 revenue of US$900 million and basic EPS of US$0.11, setting the tone for a year where top line growth led the story while profitability stayed slim. Over the past six quarters, revenue has moved from US$692.6 million in Q3 2024 to US$900 million in Q4 2025, while quarterly basic EPS has swung between a loss of US$0.07 in Q3 2025 and a high of US$0.15 in Q4 2024. This...

Crescent Energy (NYSE:CRGY) reported its latest full year and fourth quarter results, moving from a full year net loss previously to net income in the most recent year. The company recorded a loss in the fourth quarter, while adjusted earnings still came in above analyst expectations. Management highlighted a disciplined, returns focused growth plan built around acquisitions in key production basins. Crescent Energy focuses on acquiring and developing assets in established oil and gas...